Paul M. Wynne
Directeur/Membre du Conseil chez Gelteq Ltd.
Profil
Paul M.
Wynne is an Independent Director at Gelteq Ltd.
since 2022 and the Manager-Medicines Manufacturing Innovation Centre at Monash University since 2016.
He completed his undergraduate degree in 1984, graduate degree in 1987, and doctorate in 2001, all from RMIT University.
Postes actifs de Paul M. Wynne
| Sociétés | Poste | Début |
|---|---|---|
Gelteq Ltd.
 Gelteq Ltd. Pharmaceuticals: MajorHealth Technology Gelteq Ltd. is a clinical and science-based company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia. | Directeur/Membre du Conseil | 01/04/2022 |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | Corporate Officer/Principal | 01/11/2016 |
Formation de Paul M. Wynne
| RMIT University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Gelteq Ltd.
Gelteq Ltd. Pharmaceuticals: MajorHealth Technology Gelteq Ltd. is a clinical and science-based company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia. | Health Technology |
